Cite
HARVARD Citation
Schwarer, A. et al. (2018). A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schwarer, A. et al. (2018). A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2 (6), p. . [Online].